Situation: A 58-year-old man with alcohol-associated cirrhosis is admitted with tense ascites and mild confusion. He weighs 72 kg, has no peripheral edema, and has had no alcohol for 2 weeks. He takes spironolactone 100 mg and furosemide 40 mg daily, and lactulose three times a day. He asks why he must keep taking lactulose even though he is not constipated. Which explanation is accurate?

Colonic bacteria break lactulose into acids that convert ammonia to ammonium, which cannot be absorbed, and the laxative effect speeds its removal in the stool. It is titrated to 2–3 soft stools a day to treat and prevent hepatic encephalopathy, not to treat constipation. Rifaximin is the drug that acts on ammonia-producing bacteria.

Core mechanism
Lactulose is a nonabsorbable disaccharide that works primarily in the colon. Colonic bacteria ferment it into short-chain organic acids, which lower the intraluminal pH. In that acidic environment, ammonia (NH₃) accepts a proton and is converted to ammonium (NH₄⁺). Ammonium is poorly absorbed across the bowel wall, so it remains trapped in the lumen and is excreted in the stool. The osmotic and laxative effects of lactulose then accelerate stool transit, reducing the time available for ammonia to be reabsorbed into the portal circulation. The therapeutic goal is not to relieve constipation but to titrate the dose until the patient passes 2–3 soft stools per day, which provides continuous ammonia elimination and prevents hepatic encephalopathy. ^[3]

Why the other options are incorrect
Option 1 describes an osmotic mechanism that does draw water into the bowel, but that fluid shift is not the reason lactulose is used in cirrhosis. The fluid pulled into the gut does not meaningfully reduce tense ascites, and using lactulose for that purpose would be ineffective and potentially dangerous. Option 3 is incorrect because lactulose does not enhance hepatic urea-cycle activity. The impaired conversion of ammonia to urea is a consequence of hepatocellular dysfunction, and lactulose acts downstream in the colon rather than in the liver. Option 4 describes the mechanism of rifaximin, a poorly absorbed antibiotic that suppresses ammonia-producing gut flora. Rifaximin is often added when lactulose alone is insufficient, but it is a different drug with a different target. ^[4]

Clinical application in this patient
The patient has alcohol-associated cirrhosis, tense ascites, and mild confusion, which is consistent with covert or early overt hepatic encephalopathy. He has been abstinent from alcohol for 2 weeks, but hepatic encephalopathy can still occur because the underlying cirrhosis and portosystemic shunting persist. His current regimen of spironolactone 100 mg and furosemide 40 mg daily addresses ascites, while lactulose three times daily addresses the neurocognitive component. The absence of constipation does not mean lactulose should be stopped; the stool frequency is the marker used to adjust the dose, not a side effect to be avoided. ^[3]

Pathophysiology link to ammonia
In advanced liver disease, the urea cycle is disrupted, leading to increased ammonia production and impaired clearance. Ammonia crosses the blood–brain barrier and contributes to neuropsychiatric dysfunction ranging from subtle attention deficits to disorientation and coma. Because the exact pathophysiology of hepatic encephalopathy is multifactorial and not fully understood, ammonia reduction remains a central therapeutic strategy even though other mechanisms, such as inflammation and oxidative stress, are also recognized. Key point! Lactulose lowers serum ammonia by trapping it as ammonium in the gut, not by repairing hepatic metabolism. Watch out! Do not confuse lactulose with rifaximin—lactulose changes the chemical form of ammonia, while rifaximin reduces the bacterial load that produces it. ^[4]

Drug	Primary action	Effect on ammonia	Dose titration goal
Lactulose	Fermented to organic acids; lowers colonic pH	Converts NH₃ to trapped NH₄⁺; accelerates stool transit	2–3 soft stools daily
Rifaximin	Poorly absorbed gut-selective antibiotic	Reduces ammonia-producing colonic bacteria	Added for recurrent or refractory hepatic encephalopathy